456. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment

BACKGROUND: There are reports of immunocompromised patients who have received B cell depleting treatment becoming infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and sustaining viral shedding for months or longer. Detailed information on intrahost viral evolution in SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sangmin, Lee, Yongseop, Han, Min, Lee, Jung Ah, Kim, Jung Ho, Jeong, Su Jin, Ku, Nam Su, Choi, Jun Yong, Yeom, Joon-sup, Ahn, Jin Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676891/
http://dx.doi.org/10.1093/ofid/ofad500.526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676891/
http://dx.doi.org/10.1093/ofid/ofad500.526

Ejemplares similares